Study of PAC-1 and Entrectinib for Patients With Metastatic Uveal Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Uveal Melanoma
Related studies linked through entity extraction aliases.
A Prospective Natural History Study in Uveal Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Uveal Melanoma and Brachytheraphy: Long-term Outcomes.
- Status
- COMPLETED
- Phase
- N/A
A Study of RO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positive Melanomas
- Status
- COMPLETED
- Phase
- PHASE1
Isolated Hepatic Perfusion in Combination With Ipilimumab and Nivolumab in Patients With Uveal Melanoma Metastases
- Status
- COMPLETED
- Phase
- PHASE1
Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME)
- Status
- RECRUITING
- Phase
- NA
Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Melanoma Vaccine Against Neoantigen and Shared Antigens by CD40 Activation and TLR Agonists In Patients With Melanoma (Including Ocular Melanoma)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Durvalumab (MEDI4736) Plus Cediranib in Patients With Metastatic Uveal Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Genetic Predictors of Efficiency and Safety of ICIs in Patients With Different Malignancies (ICIPRESIST-0519)
- Status
- UNKNOWN
- Phase
- N/A
Study of the Activity of PD-1 Inhibitors in Metastatic Uveal Melanoma
- Status
- COMPLETED
- Phase
- N/A
Study of Immunotherapy Plus ADI-PEG 20 for the Treatment of Advanced Uveal Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1 Study of [225Ac]-FPI-1434 Injection
- Status
- TERMINATED
- Phase
- PHASE1
Stereotactic Body Radiation Therapy and Aflibercept in Treating Patients With Uveal Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Phase II Study of BVD-523 in Metastatic Uveal Melanoma
- Status
- TERMINATED
- Phase
- PHASE2